Sony has sold some 95,000 shares from its medical services subsidiary M3, a move that’s expected to boost the firm’s Q4 profits by $1.23 billion.
According to the UK’s GI.biz, the sale is expected to net the Sony Corporation ¥115 billion ($1.23 bn / £798m) after selling 6% of M3, accounting for 95,000 shares. However, Sony will remain the majority shareholder in the business.
It’s part of Sony’s restructuring effort, with a similar move happening one month ago, when the firm sold its New York headquarters to investors led by the Chetrit Group for $1.1 billion.
A big part of today’s PlayStation 4 announcement, it seems, will be Gaikai’s integration into the company’s cloud offering moving forward.
Games Thirst – Amazing Life

Pingback: Google
Pingback: Google